Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AYRES P. R., WILLIARD T. B. Serum glutamic oxalacetic transaminase levels in 266 surgical patients. Ann Intern Med. 1960 Jun;52:1279–1288. doi: 10.7326/0003-4819-52-6-1279. [DOI] [PubMed] [Google Scholar]
- Abbruzzese A., Jeffery R. L. Marked elevations of serum glutamic oxalacetic transaminase and lactic dehydrogenase activity in chronic extraheptic biliary disease. Am J Dig Dis. 1969 May;14(5):332–338. doi: 10.1007/BF02235945. [DOI] [PubMed] [Google Scholar]
- BODANSKY O. Diagnostic applications of enzymes in medicine. General enzymological aspects. Am J Med. 1959 Dec;27:861–874. doi: 10.1016/0002-9343(59)90172-x. [DOI] [PubMed] [Google Scholar]
- Bates B., Yellin J. A. The yield of multiphasic screening. JAMA. 1972 Oct 2;222(1):74–78. [PubMed] [Google Scholar]
- Burckhardt D., Ladue J. S. Provocation of serum enzyme activity in cholecystectomized patients given opiates. Am J Gastroenterol. 1966 Jul;46(1):43–50. [PubMed] [Google Scholar]
- CHINSKY M., SHERRY S. Serum transaminase as a diagnostic aid. AMA Arch Intern Med. 1957 Apr;99(4):556–568. doi: 10.1001/archinte.1957.00260040056006. [DOI] [PubMed] [Google Scholar]
- CONRAD F. G. Transaminase. N Engl J Med. 1957 Mar 28;256(13):602–608. doi: 10.1056/NEJM195703282561306. [DOI] [PubMed] [Google Scholar]
- Clermont R. J., Chalmers T. C. The transaminase tests in liver disease. Medicine (Baltimore) 1967 Mar;46(2):197–207. doi: 10.1097/00005792-196703000-00012. [DOI] [PubMed] [Google Scholar]
- DUNN M., MARTINS J., REISSMANN K. R. The disappearance rate of glutamic oxalacetic transaminase from the circulation and its distribution in the body's fluid compartments and secretions. J Lab Clin Med. 1958 Feb;51(2):259–265. [PubMed] [Google Scholar]
- Elveback L. R. How high is high? A proposed alternative to the normal range. Mayo Clin Proc. 1972 Feb;47(2):93–97. [PubMed] [Google Scholar]
- FOULK W. T., FLEISHER G. A. Serum glutamic-oxalacetic transaminase in acute pancreatitis. Gastroenterology. 1958 Oct;35(4):375–380. [PubMed] [Google Scholar]
- FRAGGE R. G., KOPEL F. B., IGLAUER A. Serum glutamic oxalacetic transaminase (SGO-T) in conngestive heart failure: clinical study and review of the literature. Ann Intern Med. 1960 May;52:1042–1050. doi: 10.7326/0003-4819-52-5-1042. [DOI] [PubMed] [Google Scholar]
- Friedman G. D., Goldberg M., Ahuja J. N., Siegelaub A. B., Bassis M. L., Collen M. I. Biochemical screening tests. Effect of panel size on medical care. Arch Intern Med. 1972 Jan;129(1):91–97. doi: 10.1001/archinte.129.1.91. [DOI] [PubMed] [Google Scholar]
- Ginsberg A. L. Very high levels of SGOT and LDH in patients with extrahepatic biliary tract obstruction. Am J Dig Dis. 1970 Sep;15(9):803–807. doi: 10.1007/BF02236040. [DOI] [PubMed] [Google Scholar]
- Glynn K. P., Cafaro A. F., Fowler C. W., Stead W. W. False elevations of serum glutamic-oxalacetic transaminase due to para-aminosalicylic acid. Ann Intern Med. 1970 Apr;72(4):525–527. doi: 10.7326/0003-4819-72-4-525. [DOI] [PubMed] [Google Scholar]
- KARMEN A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955 Jan;34(1):131–133. [PubMed] [Google Scholar]
- KARMEN A., WROBLEWSKI F., LADUE J. S. Transaminase activity in human blood. J Clin Invest. 1955 Jan;34(1):126–131. doi: 10.1172/JCI103055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KORN R. J., WEST M., DAVIS D. P., GIBBEL M. I. Serum enzymes: their value in diagnosis and management of surgical diseases. Surg Clin North Am. 1962 Feb;42:249–266. doi: 10.1016/s0039-6109(16)36597-5. [DOI] [PubMed] [Google Scholar]
- Knirsch A. K., Gralla E. J. Abnormal serum transaminase levels after parenteral ampicillin and carbenicillin administration. N Engl J Med. 1970 May 7;282(19):1081–1082. doi: 10.1056/NEJM197005072821907. [DOI] [PubMed] [Google Scholar]
- LOGAN R. G., MOWRY F. M., JUDGE R. D. Cardiac failure simulating viral hepatitis. Three cases with serum transaminase levels above 1,000. Ann Intern Med. 1962 May;56:784–788. doi: 10.7326/0003-4819-56-5-784. [DOI] [PubMed] [Google Scholar]
- MOORE C. B., BIRCHALL R., HORACK H. M., BATSON H. M. Changes in serum glutamic oxalacetic transaminase in patients with diseases of the heart, liver or musculoskeletal systems. Am J Med Sci. 1957 Nov;234(5):528–537. [PubMed] [Google Scholar]
- MOSSBERG S. M., BLOOM A., BERKOWITZ J., ROSS G. Serum enzyme activities following morphine. A study of transaminase and alkaline phosphatase levels in normal persons and those with gallbladder disease. Arch Intern Med. 1962 Apr;109:429–437. doi: 10.1001/archinte.1962.03620160055008. [DOI] [PubMed] [Google Scholar]
- Morgenstern S., Oklander M., Auerbach J., Kaufman J., Klein B. Automated determination of serum glutamic oxaloacetic transaminase. Clin Chem. 1966 Feb;12(2):95–111. [PubMed] [Google Scholar]
- Rang M. The Ulysses syndrome. Can Med Assoc J. 1972 Jan 22;106(2):122–123. [PMC free article] [PubMed] [Google Scholar]
- SHUSTER F., NAPIER E. A., Jr, HENLEY K. S. SERUM TRANSAMINASE ACTIVITY FOLLOWING MORPHINE, MEPERIDINE AND CODEINE IN NORMALS. Am J Med Sci. 1963 Dec;246:714–716. doi: 10.1097/00000441-196312000-00012. [DOI] [PubMed] [Google Scholar]
- Sabath L. D., Gerstein D. A., Finland M. Serum glutamic oxalacetic transaminase. False elevations during administration of erythromycin. N Engl J Med. 1968 Nov 21;279(21):1137–1139. doi: 10.1056/NEJM196811212792104. [DOI] [PubMed] [Google Scholar]
- Schneiderman L. J., DeSalvo L., Baylor S., Wolf P. L. The "abnormal" screening laboratory results. Its effect on physician and patient. Arch Intern Med. 1972 Jan;129(1):88–90. [PubMed] [Google Scholar]
- WROBLEWSKI F. The clinical significance of transaminase activities of serum. Am J Med. 1959 Dec;27:911–923. doi: 10.1016/0002-9343(59)90175-5. [DOI] [PubMed] [Google Scholar]
- ZIMMERMAN H. J., WEST M. SERUM ENZYMES IN GASTROINTESTINAL DISEASES. Med Clin North Am. 1964 Jan;48:189–214. doi: 10.1016/s0025-7125(16)33496-4. [DOI] [PubMed] [Google Scholar]
